SCS Capital Management’s Abbott ABT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$14.3M Buy
144,212
+127,995
+789% +$13.4M 0.13% 90
2026
Q2
$1.47M Sell
16,217
-2,197
-12% -$201K 0.01% 243
2026
Q1
$1.89M Buy
18,414
+545
+3% +$61.5K 0.02% 208
2025
Q4
$2.24M Sell
17,869
-1,105
-6% -$141K 0.02% 202
2025
Q3
$2.54M Sell
18,974
-1,408
-7% -$185K 0.03% 190
2025
Q2
$2.77M Sell
20,382
-492
-2% -$64.9K 0.03% 193
2025
Q1
$2.77M Buy
+20,874
New +$2.66M 0.04% 169

Other funds holding ABT

SCS Capital Management's ABT Position: Q3 2026 in Review

SCS Capital Management increased its Abbott (ABT) stake by 789% in Q3 2026, buying an estimated $13.4M and bringing the position to 144,212 shares worth $14.3M. The position accounts for 0.13% of the portfolio, ranked #90.

SCS Capital Management first reported a position in ABT in Q1 2025 and has held it in 7 quarters since. 2,662 funds tracked by Wall St. Rank hold ABT as of Q3 2026.

  • SCS Capital Management held 144,212 shares of Abbott worth $14.3M as of Q3 2026.
  • SCS Capital Management bought 127,995 Abbott shares in Q3 2026, an estimated $13.4M.
  • Abbott made up 0.13% of SCS Capital Management's portfolio in Q3 2026, its #90 holding.
  • SCS Capital Management first reported a position in Abbott in Q1 2025 and has held it in 7 quarters since.
  • 2,662 funds tracked by Wall St. Rank held Abbott as of Q3 2026.

Based on SCS Capital Management's 13F filing for Q3 2026, filed 12 Nov 2026.